Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
US
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
02 Avr 2025
Equity Research Nosa Plugs: Cash flow in the black, goal achieved
Equity Research
Nosa Plugs
20 Fév 2025
Equity research Nosa Plugs Q4, 2024: Strong growth and announced M&A strategy
Equity Research
Nosa Plugs
14 Fév 2025
Equity Research Nosa Plugs: First impression Q4, 2024
Equity Research
Nosa Plugs
19 Déc 2024
Equity Research Nosa Plugs: Drug Delivery patent submitted
Equity Research
Nosa Plugs
19 Nov 2024
Equity research Nosa Plugs Q3, 2024: Strong growth with a rise in valuation on the cards
Equity Research
Nosa Plugs
08 Nov 2024
Equity Research Nosa Plugs: First impression Q3, 2024
Equity Research
Nosa Plugs
29 Août 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Equity Research
Nosa Plugs
23 Août 2024
Equity Research Nosa Plugs: First impression Q2, 2024
Equity Research
Nosa Plugs
20 Juin 2024
Equity Research Nosa Plugs: New orders and distributor agreements
Equity Research
Nosa Plugs
17 Mai 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Equity Research
Nosa Plugs
21 Fév 2024
Equity research Nosa Plugs Q4, 2023: Record-breaking sales funding the pipeline
Equity Research
Nosa Plugs
16 Fév 2024
Equity Research Nosa Plugs: First impression Q4, 2023
Equity Research
Nosa Plugs
06 Fév 2024
Equity Research Nosa Plugs: drug delivery taking a big first step
Equity Research
Nosa Plugs
11 Déc 2023
Equity research Nosa Plugs: Directed share issues to deliver Nosa to the clinic
Equity Research
Nosa Plugs
16 Nov 2023
Equity research Nosa Plugs Q3, 2023: Moving ahead of schedule
Equity Research
Nosa Plugs
10 Nov 2023
Equity Research Nosa Plugs: First impression Q3, 2023
Equity Research
Nosa Plugs
22 Sep 2023
Carlsquare Equity Research: Nordic Life Science sector update
Equity Research
Kancera
19 Sep 2023
Equity research Nosa Plugs: Smell training launching sooner than expected
Equity Research
Nosa Plugs
28 Août 2023
Initiation of coverage Nosa Plugs: Smelling success, plugging a hole in the market
Equity Research
Nosa Plugs
02 Juin 2023
Mrkt BUZZ Nosa Plugs: What's that smell? Opportunity
Equity Research
Nosa Plugs
1
2